Injective vs DoubleZero Staked SOL Staking
Side-by-side comparison of INJ and DZSOL staking yields, risk, and key metrics. Updated every 4 hours.
Detailed comparison
Injective vs DoubleZero Staked SOL: which should you stake?
Injective currently offers the higher APY at 7.40% compared to DoubleZero Staked SOL's 4.82%. That's a 2.58 percentage point difference in annual yield.
In terms of market cap, Injective is the larger asset at $486.44M, which generally indicates more liquidity and lower volatility risk.
Both assets can be staked through various platforms and protocols. Consider diversifying across both rather than choosing one exclusively — this spreads your risk across different networks and ecosystems.
Injective vs DoubleZero Staked SOL — common questions
Is Injective or DoubleZero Staked SOL better for staking?
Injective currently offers a higher staking APY at 7.40% compared to DoubleZero Staked SOL's 4.82%. However, the best choice depends on your risk tolerance, investment horizon, and portfolio strategy.
What is the APY difference between Injective and DoubleZero Staked SOL?
Injective offers 7.40% APY while DoubleZero Staked SOL offers 4.82% APY — a difference of 2.58 percentage points.
Which is safer to stake: INJ or DZSOL?
Injective has a medium risk rating while DoubleZero Staked SOL has a medium risk rating. Lower risk typically means a more established network with stronger validator infrastructure.
Can I stake both INJ and DZSOL?
Yes, diversifying across multiple staking assets is a common strategy. Staking both Injective and DoubleZero Staked SOL spreads your risk across different networks and protocols.